The Food and Drug Administration approved a vaccine from Pfizer that protects infants from respiratory syncytial virus, the leading cause of hospitalization among babies in the U.S. The company's ...
An advisory panel for the U.S. Centers of Disease Control and Prevention on Friday recommended that a vaccine for respiratory ...
The FDA approved the first vaccine for pregnant women to prevent RSV in infants. The vaccine would allow babies to be born ...
Two new vaccines for respiratory syncytial virus (RSV) are available this year for people aged 60 and older, as well as for ...
The Food and Drug Administration authorized the emergency use of its Pfizer-BioNTech vaccine for adolescents age 12 to 15 today, according to the New York Times. Authorization is given for the ...
The new shots are similar to previously approved formulas but were updated to target strains of the virus descended from ...
The latest COVID-19 boosters could be approved and on their way to health systems this week. The question: Will people go and ...
The U.S. Centers for Disease Control and Prevention (CDC) on Friday backed Pfizer's respiratory syncytial virus (RSV) vaccine ...
US regulators approved updated versions of the COVID-19 vaccines made by Pfizer Inc. and Moderna Inc. Monday as ...
LEXINGTON, Ky. (WKYT) - The FDA approved updated COVID-19 boosters for Moderna and Pfizer vaccinations Monday. This comes ...
In a nearly unanimous vote, advisors to the Centers for Disease Control and Prevention have recommended a new vaccine to ...
WASHINGTON — U.S. regulators on Monday approved the first RSV vaccine for pregnant women so their babies will be born with protection against the scary respiratory infection. RSV is notorious ...
